pentosidine has been researched along with Hyperlipemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Yahia, S; Bouzidi, H; Hammami, M; Kerkeni, M; Letaief, A; Saïdi, A | 1 |
| Alderson, NL; Baynes, JW; Beattie, RJ; Chachich, ME; Nachtigal, M; Thorpe, SR; Youssef, NN | 1 |
| Cenuse, M; Costache, G; Georgescu, A; Jinga, VV; Popov, D; Simionescu, M | 1 |
3 other study(ies) available for pentosidine and Hyperlipemia
| Article | Year |
|---|---|
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Topics: Aged; Arginine; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Hyperlipidemias; Hypertension; Lysine; Male; Microvessels; Middle Aged; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Up-Regulation | 2013 |
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.
Topics: Animals; Aorta; Arginine; Blood Glucose; Blood Pressure; Collagen; Female; Glycation End Products, Advanced; Hyperlipidemias; Hypertension; Kidney; Kidney Diseases; Lysine; Pyridoxamine; Rats; Rats, Zucker; Skin; Weight Gain | 2003 |
The effects of simultaneous hyperlipemia-hyperglycemia on the resistance arteries, myocardium and kidney glomeruli.
Topics: Acetylcholine; Animals; Arginine; Blood Glucose; Cholesterol; Cholesterol, Dietary; Collagen; Cricetinae; Diabetes Mellitus, Experimental; Erythrocytes; Glomerular Mesangium; Glycation End Products, Advanced; Hyperlipidemias; Hypertrophy, Left Ventricular; Lysine; Male; Mesenteric Arteries; Mesocricetus; Myocardium; Norepinephrine; Osmotic Fragility; Peptidyl-Dipeptidase A; Vascular Resistance | 2000 |